DRG 755

Medical DRG

Malignancy, Female Reproductive System with CC

TypeMedicalMDC13Dx Codes58

What is MS-DRG 755?

MS-DRG 755 is a Medical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 13 (MDC 13) with a Complication or Comorbidity (CC). It maps to 58 ICD-10-CM diagnosis codes. For FY 2026 it carries a relative weight of 1.0878 with a geometric mean length of stay of 3.2 days and an arithmetic mean of 4.3 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Medical DRG
Diagnosis-driven grouping
Linked Codes
58 diagnosis
Billable Dx
100%
58 of 58 shown

FY 2026 Payment Data

Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).

Relative Weight
1.0878
Payment multiplier vs. average case (1.0)
Geometric Mean LOS
3.2 days
Used for transfer payment calculations
Arithmetic Mean LOS
4.3 days
Average length of stay
Post-Acute Transfer
No
Not subject to the transfer policy

Related MS-DRGs in This Severity Group

The same clinical condition is split into separate DRGs by complication severity. MCC pays more than CC, which pays more than no CC/MCC.

DRGTitleRel. WeightGMLOS
754Malignancy, Female Reproductive System with MCC1.84175.1 days
755Malignancy, Female Reproductive System with CCThis page1.08783.2 days
756Malignancy, Female Reproductive System without CC/MCC0.96052 days

Linked ICD-10-CM Diagnosis Mappings

  • C51.0

    Malignant neoplasm of labium majus

    BillableChapter 2
  • C51.1

    Malignant neoplasm of labium minus

    BillableChapter 2
  • C51.2

    Malignant neoplasm of clitoris

    BillableChapter 2
  • C51.8

    Malignant neoplasm of overlapping sites of vulva

    BillableChapter 2
  • C51.9

    Malignant neoplasm of vulva, unspecified

    BillableChapter 2
  • C52

    Malignant neoplasm of vagina

    BillableChapter 2
  • C53.0

    Malignant neoplasm of endocervix

    BillableChapter 2
  • C53.1

    Malignant neoplasm of exocervix

    BillableChapter 2
  • C53.8

    Malignant neoplasm of overlapping sites of cervix uteri

    BillableChapter 2
  • C53.9

    Malignant neoplasm of cervix uteri, unspecified

    BillableChapter 2
  • C54.0

    Malignant neoplasm of isthmus uteri

    BillableChapter 2
  • C54.1

    Malignant neoplasm of endometrium

    BillableChapter 2
  • C54.2

    Malignant neoplasm of myometrium

    BillableChapter 2
  • C54.3

    Malignant neoplasm of fundus uteri

    BillableChapter 2
  • C54.8

    Malignant neoplasm of overlapping sites of corpus uteri

    BillableChapter 2
  • C54.9

    Malignant neoplasm of corpus uteri, unspecified

    BillableChapter 2
  • C55

    Malignant neoplasm of uterus, part unspecified

    BillableChapter 2
  • C56.1

    Malignant neoplasm of right ovary

    BillableChapter 2
  • C56.2

    Malignant neoplasm of left ovary

    BillableChapter 2
  • C56.3

    Malignant neoplasm of bilateral ovaries

    BillableChapter 2
  • C56.9

    Malignant neoplasm of unspecified ovary

    BillableChapter 2
  • C57.00

    Malignant neoplasm of unspecified fallopian tube

    BillableChapter 2
  • C57.01

    Malignant neoplasm of right fallopian tube

    BillableChapter 2
  • C57.02

    Malignant neoplasm of left fallopian tube

    BillableChapter 2
  • C57.10

    Malignant neoplasm of unspecified broad ligament

    BillableChapter 2
  • C57.11

    Malignant neoplasm of right broad ligament

    BillableChapter 2
  • C57.12

    Malignant neoplasm of left broad ligament

    BillableChapter 2
  • C57.20

    Malignant neoplasm of unspecified round ligament

    BillableChapter 2
  • C57.21

    Malignant neoplasm of right round ligament

    BillableChapter 2
  • C57.22

    Malignant neoplasm of left round ligament

    BillableChapter 2
  • C57.3

    Malignant neoplasm of parametrium

    BillableChapter 2
  • C57.4

    Malignant neoplasm of uterine adnexa, unspecified

    BillableChapter 2
  • C57.7

    Malignant neoplasm of other specified female genital organs

    BillableChapter 2
  • C57.8

    Malignant neoplasm of overlapping sites of female genital organs

    BillableChapter 2
  • C57.9

    Malignant neoplasm of female genital organ, unspecified

    BillableChapter 2
  • C58

    Malignant neoplasm of placenta

    BillableChapter 2
  • C76.3

    Malignant neoplasm of pelvis

    BillableChapter 2
  • C79.60

    Secondary malignant neoplasm of unspecified ovary

    BillableChapter 2
  • C79.61

    Secondary malignant neoplasm of right ovary

    BillableChapter 2
  • C79.62

    Secondary malignant neoplasm of left ovary

    BillableChapter 2
  • C79.63

    Secondary malignant neoplasm of bilateral ovaries

    BillableChapter 2
  • C79.82

    Secondary malignant neoplasm of genital organs

    BillableChapter 2
  • D06.0

    Carcinoma in situ of endocervix

    BillableChapter 2
  • D06.1

    Carcinoma in situ of exocervix

    BillableChapter 2
  • D06.7

    Carcinoma in situ of other parts of cervix

    BillableChapter 2
  • D06.9

    Carcinoma in situ of cervix, unspecified

    BillableChapter 2
  • D07.0

    Carcinoma in situ of endometrium

    BillableChapter 2
  • D07.1

    Carcinoma in situ of vulva

    BillableChapter 2
  • D07.2

    Carcinoma in situ of vagina

    BillableChapter 2
  • D07.30

    Carcinoma in situ of unspecified female genital organs

    BillableChapter 2
  • D07.39

    Carcinoma in situ of other female genital organs

    BillableChapter 2
  • D39.0

    Neoplasm of uncertain behavior of uterus

    BillableChapter 2
  • D39.10

    Neoplasm of uncertain behavior of unspecified ovary

    BillableChapter 2
  • D39.11

    Neoplasm of uncertain behavior of right ovary

    BillableChapter 2
  • D39.12

    Neoplasm of uncertain behavior of left ovary

    BillableChapter 2
  • D39.2

    Neoplasm of uncertain behavior of placenta

    BillableChapter 2
  • D39.8

    Neoplasm of uncertain behavior of other specified female genital organs

    BillableChapter 2
  • D39.9

    Neoplasm of uncertain behavior of female genital organ, unspecified

    BillableChapter 2